RMD RESMED INC

Overview and Growth

Fiscal 2026 results for RESMED INC combined $5.65B of revenue with net income of $1.52B and an operating cash inflow of $1.81B. Revenue of $5.65B sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 9.9% from $5.15B in fiscal 2025, increasing the company’s operating scale. The company reported diluted EPS of $10.43, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $9.51 in fiscal 2025, the current result was 9.7% higher. Asset turnover was 0.63x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The first profit layer was $3.45B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 61.1% of revenue, showing how much of the top line remained after direct costs. The reported operating result was $1.89B, capturing profitability after direct costs and the operating expenses reflected in the statements. Operating margin measured 33.4%, showing the portion of revenue preserved after the full set of operating costs. After all reported below-operating-line items, the company recorded net income of $1.52B for the fiscal year. Net margin was 26.9%, meaning that this portion of revenue remained as net income after all recognized expenses. Pretax income was $1.92B, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Measured against revenue, pretax income equaled 34.0%, adding a pre-tax profitability layer between revenue and net income. Income tax expense totaled $396.12M, providing the reported tax component that separates pretax and after-tax earnings. The income-tax provision equaled 20.6% of pretax income, showing the tax burden absorbed by the year’s earnings.

Liquidity and Capital Structure

At period end, the $8.97B asset base was financed through $2.38B of liabilities and $6.59B of equity. Current assets were $4.32B against $1.40B of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 3.1x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $1.47B in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 105.3%, excluding receivables and other current assets. Borrowings totaled $659.37M, adding a fixed financing obligation alongside the company’s equity capital. Against book equity, debt measured 0.1x, placing the company’s financial leverage in clear balance-sheet terms. Relative to total assets, debt measured 7.4%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 26.6%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 16.4% of total assets, showing the liquid cash component within the company’s broader resource base.

Cash Flow and Earnings Quality

The company reported $1.81B of operating cash flow, a cash inflow that shows the cash generated by operations. Operating cash flow equaled 1.19x of net income, showing how strongly accounting earnings converted into cash from operations. The cash-flow statement records $156.28M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 8.7% of operating cash flow, quantifying the share of cash from operations directed to investment. The combination of operating cash flow and capital spending produced $1.65B of positive free cash flow for the period. Relative to revenue, free cash flow equaled 29.2%, showing how much sales converted into cash after investment. The free-cash-flow-to-assets relationship was 18.4%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Jun 30, 2026. Analysis generated Sep 24, 2026.